Cancer Prevention News and Research

RSS

Greater adherence to lifestyle-based recommendations reduced the risk of cancers in the U.K.

The BMC Medicine study confirms that adhering to the 2018 World Cancer Research Fund/American Institute for Cancer Research recommendations significantly lowers the risk of various cancers, including breast, colorectal, and esophageal, in the UK population. This highlights the importance of lifestyle choices in cancer prevention.

30 Nov 2023

SLACOM and NCCN host the Latin American Regional Breast Cancer Summit

Today the Latin American and Caribbean Society of Medical Oncology and National Comprehensive Cancer Network host the Latin American Regional Breast Cancer Summit: Advocating and Implementing Guideline-Concordant Cancer Care for Patients.

30 Nov 2023

Study validates cancer risk reduction through lifestyle adherence

Researchers examined associations between adherence to cancer prevention recommendations by the World Cancer Research Fund (WCRF)/American Institute for Cancer Research (AICR) and cancer risk.

28 Nov 2023

Adherence to the WCRF/AICR guidelines can significantly reduce cancer risk

Greater adherence to the World Cancer Research Fund/American Institute for Cancer Research (WCRF/AICR) cancer prevention recommendations -; which encourage a healthy lifestyle -; is associated with a lower risk of all cancers combined and some individual cancers such as breast cancer.

27 Nov 2023

Eating more ultra-processed foods may increase risk of upper aerodigestive tract cancers

Eating more ultra-processed foods (UPFs) may be associated with a higher risk of developing cancers of upper aerodigestive tract (including the mouth, throat and oesophagus), according to a new study led by researchers from the University of Bristol and the International Agency for Research on Cancer (IARC).

22 Nov 2023

MOSAIC center aims to revolutionize glioblastoma treatment with image-based mathematical models

Mayo Clinic Comprehensive Cancer Center and Columbia University received a five-year, $10.6 million U54 center grant from the National Cancer Institute (NCI) to further study combining the molecular analysis of glioblastoma with MRI.

16 Nov 2023

Study: 1.3 million lives lost every year to cancers caused by smoking tobacco across 7 countries

Every year 1.3 million lives are lost to cancers caused by smoking tobacco across the UK, US and BRICS nations (Brazil, Russia, India, China and South Africa), according to a new study, funded by Cancer Research UK.

15 Nov 2023

Stand Up To Cancer unveils new gastroesophageal cancer research teams and awards

Stand Up To Cancer (SU2C) today announced three Research Teams focused on bringing new therapies to clinical trials for the treatment of gastroesophageal cancer (GEC).

15 Nov 2023

Preclinical research points to a promising new treatment option for pancreatic cancer patients

Preclinical research published in the Journal for ImmunoTherapy of Cancer points to a promising new treatment option for people with pancreatic cancer.

10 Nov 2023

NCI grants $5 million to UTHealth Houston for cancer control research in Mexico and Latin America

A five-year, $5 million grant has been awarded by the National Cancer Institute (NCI) to the UTHealth Houston Institute for Implementation Science to support research and training in implementation science, with a focus on improving cancer control efforts in Mexico and Latin America.

10 Nov 2023

FORTE accrues first 1000 participants for highly anticipated colorectal cancer prevention trial

FORTE (NRG-CC005) is a highly anticipated colorectal cancer prevention trial led by NRG Oncology examining surveillance colonoscopy intervals in participants who have non-advanced polyps.

9 Nov 2023

New lung cancer screening guideline expands eligibility to save more lives

Today, the American Cancer Society (ACS) released an update of its lung cancer screening guideline to help reduce the number of people dying from the disease due to smoking history.

1 Nov 2023

Personalized colorectal cancer screening reduces low-value care in older adults

Colorectal cancer screening is widely recommended for adults ages 45 to 75 with an average risk of developing the disease. However, many people don't realize that the benefits of screening for this type of cancer aren't always the same for older adults.

30 Oct 2023

University of Oklahoma scientist secures nearly $1 million award to advance research in computational genomics

Marmar Moussa, Ph.D., an assistant professor of computer science professor at the University of Oklahoma, has secured a nearly $1 million award from the National Institutes of Health to advance her work in computational genomics.

30 Oct 2023

Study highlights a “sunscreen paradox” and the false sense of security against skin cancer

Sunscreen usage is climbing, but so are melanoma and skin cancer rates: this, researchers say, is the sunscreen paradox.

27 Oct 2023

Researchers identify mechanism through which dietary omega 3 supplements alleviate liver condition

A study spearheaded by Oregon State University has shown why certain polyunsaturated fatty acids work to combat a dangerous liver condition, opening a new avenue of drug research for a disease that currently has no FDA-approved medications.

25 Oct 2023

Utilizing Biomarkers in Cancer Prevention, Diagnosis, and Treatment

In this interview, Grace Liu from Sino Biological discusses the crucial role of biomarkers in cancer prevention and diagnosis and how they can help guide treatment decisions.

From Sino Biological Inc. 24 Oct 2023

Mediterranean diet intervention may not improve breast cancer prognosis in high-risk patients

Researchers discuss the results of a randomized controlled trial to explore the impact of diet on breast cancer recurrence.

20 Oct 2023

Collaborative team receives NCI grant to study how to improve immunotherapy for diffuse midline gliomas

Each year, approximately 200 to 300 children in the United States are diagnosed with diffuse midline gliomas (DMG), a tumor that begins in the brain or spinal cord.

19 Oct 2023

Cervical cancer rates increasing in Appalachian Kentucky

While the overall incidence and death rates from cervical cancer have dropped in the U.S., the opposite has been occurring in Appalachian Kentucky – a steady increase. The death rate from cervical cancer in Appalachian Kentucky is now twice that of the national rate.